Switching from prednisone to dexamethasone in metastatic castration resistant prostate cancer treated with abiraterone acetate in a multicenter study

by I. Rivero Belenchón, C. Muñoz Calahorro, I. Osmán García, P. Beardo Villar, C.B. Congregado Ruíz, B. San José Ruíz Jiménez, J. Campé Bartolo, R. Llarena Ibarguren, J. Extramina Cameno, R.A. Medina López
Published 2020-07-01